The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

A New Clinical Scale for the Staging of Dementia

1982 • 6,699 citations

The Global Deterioration Scale for assessment of primary degenerative dementia

1982 • 4,700 citations

The New Zealand Medical Journal 1887-1987.

1987 • 3,703 citations

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

2002 • 3,174 citations

The Neuropsychiatric Inventory

1997 • 1,874 citations

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1992 • 1,181 citations

Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.

1988 • 1,118 citations

Neurotoxicity associated with dual actions of homocysteine at the N -methyl- <scp>d</scp> -aspartate receptor

1997 • 830 citations

Quality of life in Alzheimer's disease: Patient and caregiver reports.

1999 • 822 citations

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

2003 • 822 citations

Development of the Korean Version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): Clinical and Neuropsychological Assessment Batteries

2002 • 675 citations

Neuro‐Psychopharmacology

1962 • 595 citations

Glutamatergic substrates of drug addiction and alcoholism

2007 • 475 citations

Construct validity in the trail making test: What makes part B harder?

1995 • 400 citations

Cognitive Loss and Recovery in Long-term Alcohol Abusers

1983 • 379 citations

Ethanol and brain damage

2004 • 339 citations

Neurocognitive impairment associated with alcohol use disorders: Implications for treatment.

2002 • 313 citations

Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial

2006 • 291 citations

Neurocognitive impairment associated with alcohol use disorders: Implications for treatment.

2002 • 286 citations

Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action

2000 • 258 citations

Alcohol related dementia: proposed clinical criteria

1998 • 246 citations

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy

1997 • 220 citations

Glutamate-mediated transmission, alcohol, and alcoholism

2000 • 209 citations

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

2005 • 199 citations

Effect of physical layout in performance of the Trail Making Test.

1995 • 159 citations

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study

2007 • 159 citations

Homocysteine and brain atrophy

2005 • 151 citations

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801

2001 • 150 citations

Binge Drinking in Midlife and Dementia Risk

2005 • 139 citations

Alcohol Abuse, Cognitive Impairment, and Mortality Among Older People

2001 • 139 citations

Aging, Abstinence, and Medical Risk Factors in the Prediction of Neuropsychologic Deficit Among Long-term Alcoholics

1984 • 136 citations

Evolution of the measurement of quality of life in migraine

1997 • 124 citations

The interactive effects of age and length of abstinence on the recovery of neuropsychological functioning in chronic male alcoholics: A 2-year follow-up study

1999 • 112 citations

Effect of Memantine on Cue-Induced Alcohol Craving in Recovering Alcohol-Dependent Patients

2007 • 111 citations

Pharmacological Mechanisms of Naltrexone and Acamprosate in the Prevention of Relapse in Alcohol Dependence

2003 • 108 citations

Evidence for alcohol anti-craving properties of memantine

1996 • 107 citations

A Pilot Double‐Blind Treatment Trial of Memantine for Alcohol Dependence

2007 • 99 citations

Alcohol-Related Dementia: Validation of Diagnostic Criteria

2003 • 94 citations

A normative study of the Trail Making Test in Korean elders

2006 • 93 citations

Homocysteine as a neurotoxin in chronic alcoholism

2004 • 92 citations

Noncompetitive NMDA Receptor Antagonists with Fast Open-Channel Blocking Kinetics and Strong Voltage-Dependency as Potential Therapeutic Agents for Alzheimer's Dementia

1995 • 87 citations

Plasma homocysteine is a predictor of alcohol withdrawal seizures

2000 • 78 citations

RECOVERY OF HIPPOCAMPUS-RELATED FUNCTIONS IN CHRONIC ALCOHOLICS DURING MONITORED LONG-TERM ABSTINENCE

2006 • 74 citations

Alcoholism and Dementia

1995 • 72 citations

High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR)

2001 • 62 citations

Chronic ethanol consumption increases homocysteine accumulation in hepatocytes

2001 • 60 citations

Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine

1998 • 50 citations

Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons

2005 • 49 citations

Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism

2005 • 49 citations

ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF WERNICKE–KORSAKOFF SYNDROME−THREE FURTHER CASES SHOW RESPONSE TO DONEPEZIL

2004 • 44 citations

Homocysteine and alcoholism

2000 • 42 citations

Memantine, but not dizocilpine, ameliorates cognitive deficits in adult rats withdrawn from chronic ingestion of alcohol

2001 • 35 citations

A Study on the Reliability and Validity of Seoul-Activities of Daily Living(S-ADL)

2004 • 35 citations

Fluvoxamine treatment of alcoholic amnestic disorder

1995 • 34 citations

Primary alcoholic dementia and alcohol‐related dementia

2006 • 33 citations

A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome.

2003 • 33 citations

A CASE OF KORSAKOFF'S SYNDROME IMPROVED BY HIGH DOSES OF DONEPEZIL

2001 • 32 citations

Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?

2004 • 32 citations

Alcohol-Related Dementia: Validation of Diagnostic Criteria

2003 • 27 citations

Effect of Memantine on Cue-Induced Alcohol Craving in Recovering Alcohol-Dependent Patients

2007 • 25 citations

Memantine: pharmacological properties and clinical uses.

2004 • 24 citations

Donepezil for Alcohol‐Related Dementia: A Case Report

2004 • 18 citations

Memantine for Alcohol Dependence: An Open-label Pilot Study

2007 • 13 citations

Treatment of Chronic Organic Mental Disorders Associated with Alcoholism

1989 • 11 citations

Memantine Treatment in Alcohol Dementia: Rapid PET Changes and Clinical Course

2001 • 10 citations

Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia?

2005 • 10 citations

Tratamiento farmacológico de la psicosis de Korsakoff: revisión de la literatura y experiencia en dos casos

2002 • 8 citations

Rivastigmine in the treatment of alcohol-induced persisting dementia.

2003 • 8 citations

[Alcohol-induced cognitive impairment is reversible. Neuropsychological tests but not MRT show improvement after abstinence].

1998 • 5 citations

Correspondence

2004 • 1 citations

ACTIONS OF ETHANOL AND RELAPSE-PREVENTING AGENTS AT THE NMDA RECEPTOR.

2004 • 1 citations